期刊文献+

酒精性肝纤维化中医证候学研究 被引量:6

Study on TCM syndrome of alcoholic liver fibrosis
原文传递
导出
摘要 目的:探讨酒精性肝纤维化的中医临床证候分类方法,为临床证候规范化研究奠定基础。方法:对104例酒精性肝纤维化患者的临床资料进行问卷调查,应用主成分分析及因子分析法分析其中医证候分布特点。结果:酒精性肝纤维化临床常见6个证型,中医证候分布特点:类肝郁脾虚证>类湿热蕴结证>类瘀血阻络证>类气虚血瘀证>类肝肾阴虚证>类阳虚血瘀证,以实证为主,虚实夹杂为其特点。结论:建立酒精性肝纤维化证候分布的因子分析模型,揭示了酒精性肝纤维化的中医证候特点,为中医辨证规范化打下一定基础,并丰富了证候分类研究的方法。 Objective:To investigate the classifying method and estalish the basis of normalized study of TCM syndromes of patients with alcoholic liver fibrosis(ALF). Methods: Questinnaire investigation of 104 ALF patients was carried by principal constituent analysis and factor analysis. Results: There were six TCM syndromes common clinical in ALF. It showed that liver depression and spleen deficiency syndromeobstruction of collaterals by blood stasis syndromeretention of damp-heat syndromeqi deficiency and blood stasis syndromeyang deficiency and blood stasis syndromedeficiency syndrome of both liver and kidney yin. Characteristics of ALF was maily of excessive syndrome, and insufficiency and excess syndrome. Conclusion: The factor analytical model of sydrome distribution and characteristics of ALF established the basis of stadardazation of TCM syndrome and enriched the study method of syndrome classifi cation.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2009年第10期1358-1360,共3页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 国家“十一五”科技支撑计划项目资助(No.2006BAI08B01-7)
关键词 酒精性肝纤维化 证候研究 临床研究 Alcoholic liver fibrosis Syndrome research Clinic investigation
  • 相关文献

参考文献5

二级参考文献20

  • 1陈启光,申春悌,张华强,符为民,闵捷,王澄淑,郦永平,朱佳,史锁方,朱学云,陈晓虎,石磊,徐丽华,常惠.结构方程模型在中医证候规范标准研究中的应用[J].中国卫生统计,2005,22(1):2-4. 被引量:67
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3[1]Pessione F,Bamond MJ,Peters L,et al.Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis.Effect of alcoholic hepatitis,smoking and abstinence[J].Liver Int,2003,23(1):45-53.
  • 4[2]Chataway J.Hardman E.Thiamiene in Wernick's syndrome-how much and how long[J].Postgrad Med J,1995,71(834):249.
  • 5[3]Cabre E,Bodriguez-Iglesias P,Caballeria J,et al.Short-and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition:a multicenter randomized trial[J].Hepatology,2000,32(1):36-42.
  • 6[5]Thurman RG,Bradford BU,Limuro Y,et al.Mechanisms of alcoholic-induced hepatotoxicity:studies in rats[J].Front Biosci,1999,4(1):42.
  • 7[6]Pares A,Planas R,Torres M,et al.Effects of sily marin in alcoholic patients with cirrhosis of the liver:results of a controlled,double-blind,randomized and multicenter trial[J].J Hepatol,1998,28(4):615-621.
  • 8[7]Spahr L,Rubbia-Brandt L,Frossard JL,et al.Combination of steroids with infliximab or placebo in severe alcoholic hepatitis:arandomized controlled pilot study[J].J Hepatol,2002,37(4):448-455.
  • 9[8]Menon KV,Stadheim Kamath PS,et al.A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis[J].Am J Gastroenterol,2004,99(2):255-260.
  • 10[9]Mathurin P,Mendenhall CL,Carithers RL Jr,et al.Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH):individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe alcoholic hepatitis[J].J Hepatol,2002,36(4):480-487.

共引文献91

同被引文献98

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部